These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 21761557)
21. Direct analysis of tubulin expression in cancer cell lines by electrospray ionization mass spectrometry. Verdier-Pinard P; Wang F; Burd B; Angeletti RH; Horwitz SB; Orr GA Biochemistry; 2003 Oct; 42(41):12019-27. PubMed ID: 14556633 [TBL] [Abstract][Full Text] [Related]
22. Regulation of β-tubulin isotypes by micro-RNA 100 in MCF7 breast cancer cells. Lobert S; Jefferson B; Morris K Cytoskeleton (Hoboken); 2011 Jun; 68(6):355-62. PubMed ID: 21634028 [TBL] [Abstract][Full Text] [Related]
23. Novel mutations involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to βIII-tubulin in breast cancer. Wang W; Zhang H; Wang X; Patterson J; Winter P; Graham K; Ghosh S; Lee JC; Katsetos CD; Mackey JR; Tuszynski JA; Wong GK; Ludueña RF Protoplasma; 2017 May; 254(3):1163-1173. PubMed ID: 27943021 [TBL] [Abstract][Full Text] [Related]
24. Taxol reduces cytosolic E-cadherin and beta-catenin levels in nasopharyngeal carcinoma cell line TW-039: cross-talk between the microtubule- and actin-based cytoskeletons. Lou PJ; Chen WP; Lin CT; Chen HC; Wu JC J Cell Biochem; 2000 Sep; 79(4):542-56. PubMed ID: 10996845 [TBL] [Abstract][Full Text] [Related]
25. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells. Zhang D; Putti TC Exp Cell Res; 2010 Dec; 316(20):3522-31. PubMed ID: 20833165 [TBL] [Abstract][Full Text] [Related]
26. Stress hormones mediate drug resistance to paclitaxel in human breast cancer cells through a CDK-1-dependent pathway. Flint MS; Kim G; Hood BL; Bateman NW; Stewart NA; Conrads TP Psychoneuroendocrinology; 2009 Nov; 34(10):1533-41. PubMed ID: 19560278 [TBL] [Abstract][Full Text] [Related]
27. Proteomic analysis of human ovarian cancer paclitaxel-resistant cell lines. Cao L; Li X; Zhang Y; Peng F; Yi H; Xu Y; Li X; Wang Q Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 35(4):286-94. PubMed ID: 20448348 [TBL] [Abstract][Full Text] [Related]
28. Expression of recombinant alpha and beta tubulins from the yew Taxus cuspidata and analysis of the microtubule assembly in the presence of taxol. Kudo Y; Abe A; Ito K; Cho Y; Yotsu-Yamashita M; Konoki K Biosci Biotechnol Biochem; 2014; 78(11):1887-94. PubMed ID: 25070196 [TBL] [Abstract][Full Text] [Related]
29. Class III b-tubulin overexpression in gynecologic tumors: implications for the choice of microtubule targeted agents? English DP; Roque DM; Santin AD Expert Rev Anticancer Ther; 2013 Jan; 13(1):63-74. PubMed ID: 23259428 [TBL] [Abstract][Full Text] [Related]
30. Microtubule-interfering activity of parthenolide. Miglietta A; Bozzo F; Gabriel L; Bocca C Chem Biol Interact; 2004 Oct; 149(2-3):165-73. PubMed ID: 15501437 [TBL] [Abstract][Full Text] [Related]
31. Characterization of nuclear betaII-tubulin in tumor cells: a possible novel target for taxol. Xu K; Ludueña RF Cell Motil Cytoskeleton; 2002 Sep; 53(1):39-52. PubMed ID: 12211114 [TBL] [Abstract][Full Text] [Related]
32. Identification of a new microtubule-interacting protein Mip-90. González M; Cambiazo V; Maccioni RB Eur J Cell Biol; 1995 Jun; 67(2):158-69. PubMed ID: 7664757 [TBL] [Abstract][Full Text] [Related]
33. RanBP1 downregulation sensitizes cancer cells to taxol in a caspase-3-dependent manner. Rensen WM; Roscioli E; Tedeschi A; Mangiacasale R; Ciciarello M; Di Gioia SA; Lavia P Oncogene; 2009 Apr; 28(15):1748-58. PubMed ID: 19270727 [TBL] [Abstract][Full Text] [Related]
34. Study of multi-drug resistant mechanisms in a taxol-resistant hepatocellular carcinoma QGY-TR 50 cell line. Zhou J; Cheng SC; Luo D; Xie Y Biochem Biophys Res Commun; 2001 Feb; 280(5):1237-42. PubMed ID: 11162660 [TBL] [Abstract][Full Text] [Related]
35. Molecular dynamics simulation and free energy landscape methods in probing L215H, L217R and L225M βI-tubulin mutations causing paclitaxel resistance in cancer cells. Tripathi S; Srivastava G; Sharma A Biochem Biophys Res Commun; 2016 Aug; 476(4):273-279. PubMed ID: 27233604 [TBL] [Abstract][Full Text] [Related]
36. Identification of a novel taxol-sensitive kinase activity associated with the cytoskeleton. Wang Y; Duncan R; Ann DK; Hamm-Alvarez SF Biochem Biophys Res Commun; 2000 Nov; 277(3):525-30. PubMed ID: 11061987 [TBL] [Abstract][Full Text] [Related]
37. Identification of betaIII- and betaIV-tubulin isotypes in cold-adapted microtubules from Atlantic cod (Gadus morhua): antibody mapping and cDNA sequencing. Modig C; Olsson PE; Barasoain I; de Ines C; Andreu JM; Roach MC; Ludueña RF; Wallin M Cell Motil Cytoskeleton; 1999; 42(4):315-30. PubMed ID: 10223637 [TBL] [Abstract][Full Text] [Related]
38. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines. Ho TF; Peng YT; Chuang SM; Lin SC; Feng BL; Lu CH; Yu WJ; Chang JS; Chang CC Toxicol Appl Pharmacol; 2009 Mar; 235(2):253-60. PubMed ID: 19133282 [TBL] [Abstract][Full Text] [Related]
39. Regulation of microtubule plus end dynamics by septin 9. Nakos K; Rosenberg M; Spiliotis ET Cytoskeleton (Hoboken); 2019 Jan; 76(1):83-91. PubMed ID: 30144301 [TBL] [Abstract][Full Text] [Related]
40. Alterations in ovarian cancer cell adhesion drive taxol resistance by increasing microtubule dynamics in a FAK-dependent manner. McGrail DJ; Khambhati NN; Qi MX; Patel KS; Ravikumar N; Brandenburg CP; Dawson MR Sci Rep; 2015 Apr; 5():9529. PubMed ID: 25886093 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]